vs
Cadre Holdings, Inc.（CDRE）与捷迈邦美（ZBH）财务数据对比。点击上方公司名可切换其他公司
捷迈邦美的季度营收约是Cadre Holdings, Inc.的13.4倍（$2.2B vs $167.2M）。Cadre Holdings, Inc.净利率更高（7.0% vs 6.2%，领先0.8%）。捷迈邦美同比增速更快（10.9% vs -5.0%）。捷迈邦美自由现金流更多（$442.6M vs $18.0M）。过去两年Cadre Holdings, Inc.的营收复合增速更高（10.1% vs 9.0%）
Cadre Holdings, Inc.是美国金融科技企业，面向个人及机构客户提供房地产投资项目直投渠道，覆盖纽约等地的商业地产。公司打造的投资平台支持投资者自主选择参与的具体交易项目，且投资门槛远低于全额收购物业所需资金，让不动产投资变得更接近股票交易，获得财经媒体的广泛认可。
捷迈邦美是一家美国上市的医疗设备企业，1927年成立，最初以生产铝制夹板为核心业务，总部设于印第安纳州华沙市，是当地医疗设备产业集群的核心成员，在全球骨科医疗器械领域拥有较高知名度。
CDRE vs ZBH — 直观对比
营收规模更大
ZBH
是对方的13.4倍
$167.2M
营收增速更快
ZBH
高出15.9%
-5.0%
净利率更高
CDRE
高出0.8%
6.2%
自由现金流更多
ZBH
多$424.6M
$18.0M
两年增速更快
CDRE
近两年复合增速
9.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $167.2M | $2.2B |
| 净利润 | $11.7M | $139.4M |
| 毛利率 | 43.4% | 64.7% |
| 营业利润率 | 12.2% | 6.9% |
| 净利率 | 7.0% | 6.2% |
| 营收同比 | -5.0% | 10.9% |
| 净利润同比 | -9.6% | -41.8% |
| 每股收益（稀释后） | $0.22 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDREZBH
| Q4 25 | $167.2M | $2.2B | ||
| Q3 25 | $155.9M | $2.0B | ||
| Q2 25 | $157.1M | $2.1B | ||
| Q1 25 | $130.1M | $1.9B | ||
| Q4 24 | $176.0M | $2.0B | ||
| Q3 24 | $109.4M | $1.8B | ||
| Q2 24 | $144.3M | $1.9B | ||
| Q1 24 | $137.9M | $1.9B |
净利润CDREZBH
| Q4 25 | $11.7M | $139.4M | ||
| Q3 25 | $10.9M | $230.9M | ||
| Q2 25 | $12.2M | $152.8M | ||
| Q1 25 | $9.2M | $182.0M | ||
| Q4 24 | $13.0M | $239.5M | ||
| Q3 24 | $3.7M | $249.1M | ||
| Q2 24 | $12.6M | $242.8M | ||
| Q1 24 | $6.9M | $172.4M |
毛利率CDREZBH
| Q4 25 | 43.4% | 64.7% | ||
| Q3 25 | 42.7% | 72.1% | ||
| Q2 25 | 40.9% | 71.5% | ||
| Q1 25 | 43.1% | 71.2% | ||
| Q4 24 | 43.9% | 71.0% | ||
| Q3 24 | 36.6% | 70.5% | ||
| Q2 24 | 40.6% | 71.5% | ||
| Q1 24 | 41.8% | 72.9% |
营业利润率CDREZBH
| Q4 25 | 12.2% | 6.9% | ||
| Q3 25 | 12.0% | 17.6% | ||
| Q2 25 | 9.3% | 14.4% | ||
| Q1 25 | 10.4% | 15.3% | ||
| Q4 24 | 16.7% | 19.2% | ||
| Q3 24 | 5.0% | 15.3% | ||
| Q2 24 | 13.8% | 18.1% | ||
| Q1 24 | 8.7% | 14.1% |
净利率CDREZBH
| Q4 25 | 7.0% | 6.2% | ||
| Q3 25 | 7.0% | 11.5% | ||
| Q2 25 | 7.8% | 7.4% | ||
| Q1 25 | 7.1% | 9.5% | ||
| Q4 24 | 7.4% | 11.8% | ||
| Q3 24 | 3.3% | 13.7% | ||
| Q2 24 | 8.7% | 12.5% | ||
| Q1 24 | 5.0% | 9.1% |
每股收益（稀释后）CDREZBH
| Q4 25 | $0.22 | $0.71 | ||
| Q3 25 | $0.27 | $1.16 | ||
| Q2 25 | $0.30 | $0.77 | ||
| Q1 25 | $0.23 | $0.91 | ||
| Q4 24 | $0.32 | $1.18 | ||
| Q3 24 | $0.09 | $1.23 | ||
| Q2 24 | $0.31 | $1.18 | ||
| Q1 24 | $0.18 | $0.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $122.9M | $591.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $317.8M | $12.7B |
| 总资产 | $770.0M | $23.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CDREZBH
| Q4 25 | $122.9M | $591.9M | ||
| Q3 25 | $150.9M | $1.3B | ||
| Q2 25 | $137.5M | $556.9M | ||
| Q1 25 | $133.4M | $1.4B | ||
| Q4 24 | $124.9M | $525.5M | ||
| Q3 24 | $93.0M | $569.0M | ||
| Q2 24 | $105.9M | $420.1M | ||
| Q1 24 | $87.1M | $393.0M |
股东权益CDREZBH
| Q4 25 | $317.8M | $12.7B | ||
| Q3 25 | $340.4M | $12.8B | ||
| Q2 25 | $332.5M | $12.5B | ||
| Q1 25 | $317.6M | $12.4B | ||
| Q4 24 | $311.5M | $12.5B | ||
| Q3 24 | $300.3M | $12.4B | ||
| Q2 24 | $299.4M | $12.7B | ||
| Q1 24 | $270.7M | $12.6B |
总资产CDREZBH
| Q4 25 | $770.0M | $23.1B | ||
| Q3 25 | $792.1M | $23.5B | ||
| Q2 25 | $794.4M | $22.9B | ||
| Q1 25 | $656.3M | $22.2B | ||
| Q4 24 | $652.7M | $21.4B | ||
| Q3 24 | $616.6M | $21.7B | ||
| Q2 24 | $620.6M | $21.5B | ||
| Q1 24 | $599.4M | $21.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.3M | $517.4M |
| 自由现金流经营现金流 - 资本支出 | $18.0M | $442.6M |
| 自由现金流率自由现金流/营收 | 10.7% | 19.7% |
| 资本支出强度资本支出/营收 | 2.0% | 3.3% |
| 现金转化率经营现金流/净利润 | 1.81× | 3.71× |
| 过去12个月自由现金流最近4个季度 | $56.8M | $1.5B |
8季度趋势，按日历期对齐
经营现金流CDREZBH
| Q4 25 | $21.3M | $517.4M | ||
| Q3 25 | $22.5M | $418.7M | ||
| Q2 25 | $2.6M | $378.2M | ||
| Q1 25 | $17.4M | $382.8M | ||
| Q4 24 | $23.7M | $506.3M | ||
| Q3 24 | $-5.2M | $395.7M | ||
| Q2 24 | $11.1M | $369.4M | ||
| Q1 24 | $2.1M | $228.0M |
自由现金流CDREZBH
| Q4 25 | $18.0M | $442.6M | ||
| Q3 25 | $21.6M | $363.7M | ||
| Q2 25 | $1.2M | $328.1M | ||
| Q1 25 | $16.1M | $338.2M | ||
| Q4 24 | $22.4M | $454.8M | ||
| Q3 24 | $-6.2M | $351.2M | ||
| Q2 24 | $9.1M | $316.7M | ||
| Q1 24 | $794.0K | $172.9M |
自由现金流率CDREZBH
| Q4 25 | 10.7% | 19.7% | ||
| Q3 25 | 13.9% | 18.2% | ||
| Q2 25 | 0.7% | 15.8% | ||
| Q1 25 | 12.4% | 17.7% | ||
| Q4 24 | 12.7% | 22.5% | ||
| Q3 24 | -5.7% | 19.3% | ||
| Q2 24 | 6.3% | 16.3% | ||
| Q1 24 | 0.6% | 9.2% |
资本支出强度CDREZBH
| Q4 25 | 2.0% | 3.3% | ||
| Q3 25 | 0.5% | 2.7% | ||
| Q2 25 | 0.9% | 2.4% | ||
| Q1 25 | 1.0% | 2.3% | ||
| Q4 24 | 0.7% | 2.5% | ||
| Q3 24 | 0.9% | 2.4% | ||
| Q2 24 | 1.4% | 2.7% | ||
| Q1 24 | 1.0% | 2.9% |
现金转化率CDREZBH
| Q4 25 | 1.81× | 3.71× | ||
| Q3 25 | 2.05× | 1.81× | ||
| Q2 25 | 0.21× | 2.48× | ||
| Q1 25 | 1.88× | 2.10× | ||
| Q4 24 | 1.83× | 2.11× | ||
| Q3 24 | -1.43× | 1.59× | ||
| Q2 24 | 0.89× | 1.52× | ||
| Q1 24 | 0.31× | 1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDRE
| U.s.state And Local Agencies | $72.7M | 43% |
| Other | $48.6M | 29% |
| U.s.Federal Agencies | $31.6M | 19% |
| Commercial | $12.0M | 7% |
ZBH
| Knees | $911.0M | 41% |
| SET | $587.6M | 26% |
| Hips | $555.4M | 25% |
| Technology And Data Bone Cement And Surgical | $189.8M | 8% |
